Michael Hutton, PhD
Affiliations: | Neuroscience | Mayo Clinic Jacksonville, Jacksonville, FL, United States |
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=77Website:
http://www.azalz.org/Scientists/Directory-of-Scientists/Michael-Hutton.aspxGoogle:
"Michael Hutton"Mean distance: 18.74 (cluster 28) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree
Children
Sign in to add trainee| Cathy A. Andorfer | grad student | Mayo Clinic Jacksonville | |
| Zdenek Berger | grad student | Mayo Clinic Jacksonville | |
| Chad A. Dickey | post-doc | Mayo Clinic Jacksonville | |
| Rosa Rademakers | post-doc | Mayo Clinic Jacksonville | |
| Marjon van Slegtenhorst | post-doc | Mayo Clinic Jacksonville | |
| Jada Lewis | post-doc | 1998-2001 | Mayo Clinic Jacksonville |
| Stacey Melquist | post-doc | 2000-2008 | Mayo Clinic Jacksonville |
| Jason L. Eriksen | research scientist | 2003-2008 | Mayo Clinic Jacksonville |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kielbasa W, Goldsmith P, Donnelly KB, et al. (2024) Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 10: e70020 |
| Katsikoudi A, Ficulle E, Cavallini A, et al. (2020) Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures. The Journal of Biological Chemistry |
| Hayashi ML, Lu J, Wu S, et al. (2017) Aggregate-Selective Anti-Tau Antibody Mc-1 Demonstrated Robust In Vitro And In Vivo Activity To Neutralize Transmissible Tau And Reduce Tau Pathology Alzheimers & Dementia. 13: 592 |
| Sher E, Mazzo F, Hutton M, et al. (2017) REGULATED RELEASE OF HYPER-PHOSPHORYLATED, AGGREGATED AND SEEDING COMPETENT TAU FROM RODENT BRAINS AND HUMAN SYNAPTOSOMES Alzheimer's & Dementia. 13: P205-P206 |
| Mead E, Kestoras D, Gibson Y, et al. (2016) Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation. Journal of Alzheimer's Disease : Jad |
| Holtzman DM, Carrillo MC, Hendrix JA, et al. (2016) Tau: From research to clinical development. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Hardy J, Villemagne V, Devous M, et al. (2016) Disentangling the interaction between amyloid and tau: where are we now? Neurobiology of Aging. 39 |
| McCarthy A, Lonergan R, Olszewska DA, et al. (2015) Closing the tau loop: the missing tau mutation. Brain : a Journal of Neurology |
| Falcon B, Cavallini A, Angers R, et al. (2015) Conformation determines the seeding potencies of native and recombinant Tau aggregates. The Journal of Biological Chemistry. 290: 1049-65 |
| Rao MV, McBrayer MK, Campbell J, et al. (2014) Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 9222-34 |